| Development of glaucoma medications and medical treatment principles | Selim DOĞANAY,CEM ÇANKAYA | 179–185 |
| Monotherapy in glaucoma | Oya TEKELİ | 186–188 |
| Ahmed glaucoma valve implantation in treatment resistant glaucoma | Torun Banu ACAR,Murat HAMURCU,Mehmet Şahin SEVİM,Suphi ACAR | 189–194 |
| Assessment of distribution of the complications in the first 300 cases of phacoemulsification for beginners | ŞEYHMUS ARI,Evşen Sina DEVECİ,İhsan ÇAÇA | 195–198 |
| Evaluation of the astigmatic profile in our cataract surgery patients | Cihan ÜNLÜ,Turan Ece VURAL,MUSTAFA GÜRKAN ERDOĞAN,Sezgin Betül İlkay AKÇAY,Hüseyin Bayramlar | 199–202 |
| Posterior subcapsular cataract formation after intravitreal triamcinolone injection | NAZMİYE EROL,Seyhan TOPBAŞ,Ahmet ÖZER | 203–206 |
| Optic disk changes in patients with age related macula degeneration | Nurşen ARITÜRK,Mehmet AYKUT | 207–212 |
| The effect of intraoperative viscoelastic injection under the scleral flap on early postoperative trabeculectomy complications | Emine ŞEN,Pınar NALÇACIOĞLU,Alper YAZICI,F. Nur AKSAKAL,Gültekin KÖKLÜ,Faruk ÖZTÜRK | 213–217 |
| Retinal nerve fiber layer thickness measurement using optical coherence tomography in healthy children | Seren PEHLİVANLIOĞLU,Serpil AKAR,Birsen GÖKYİĞİT,Ali EREN,Şükrü BAYRAKTAR,Ömer Faruk YILMAZ | 218–222 |
| Hematologic, immunologic and bıochemical evaluation in normal tension glaucoma | Osman İNCEL,Oya TEKELİ,Erol TURAÇLI | 223–227 |
| Posterior lentikonusun yüksek çözünürlüklü ön segment optik koherens tomografi ile görüntülenmesi | Ebru GÖRGÜN,Nursal Melda YENEREL,Raciha Beril KÜÇÜMEN,Umut Aslı DİNÇ,Ferda ÇİFTÇİ | 228–230 |
| Management of glaucoma in a patient with Klippel-trenaunay syndrome | EMRE AYINTAP,Uğurcan KESKİN,Mesut COŞKUN,ÖZGÜR İLHAN ÇELİK,Ayhan Esra TUZCU,Hüseyin ÖKSÜZ | 231–234 |
| Patient with terminal stage steroid-induced glaucoma who was unaware of his illness |